2018 Anticancer research

Atypical Protein Kinase C lambda/iota Expression Is Associated with Malignancy of Oral Squamous Cell Carcinoma.

, , , , , , , , ,

Anticancer research Vol. 38 (11) : 6291-6297 • Nov 2018

BACKGROUND/AIM: Atypical protein kinase C lambda/iota (aPKClambda/iota) is a cell polarity-regulator localized in the tight junction and apical membrane in epithelial cells. Previous studies suggested that aPKClambda/iota overexpression and abnormal localization were involved in tumor progression in several cancers. We investigated the relationship between aPKClambda/iota and oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: The correlation between the aPKClambda/iota expression and the clinicopathological parameters in 76 OSCC cases was examined using immunohistochemical analyses. RESULTS: aPKClambda/iota overexpression was observed in 36.8% of cases. aPKClambda/iota expression was more intense in poorly differentiated OSCC and younger patients (<60 years of age). Although expression of aPKClambda/iota was not significantly associated with clinical parameters, the correlation was found between aPKClambda/iota localization and progression-free survival. CONCLUSION: This is the first study to assess the association of aPKClambda/iota expression in OSCC with clinical results. Expression and localization of aPKClambda/iota may be involved in the degree of malignancy in OSCC.

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.
PICO Elements

No PICO elements extracted yet. Click "Extract PICO" to analyze this paper.

Paper Details
MeSH Terms
+3 more
Associated Data

No associated datasets or code repositories found for this paper.

Related Papers

Related paper suggestions will be available in future updates.